The PharmaMarketing Summit 2027, scheduled for January 21 to 22 at the Four Seasons Hotel Westlake Village, will feature a speaker lineup drawn from leading pharmaceutical companies, offering attendees direct access to executives managing commercial strategy across some of the industry's most closely watched therapeutic areas.
Pugliese leads data and intelligence strategy within one of the industry's fastest-moving therapeutic categories. His session will address how analytics is being used to inform commercial decisions in a market defined by rapid competitive change.
Whitelock brings a global perspective on value and access strategy, with insight into how companies structure payer communication and pricing strategy across multiple markets simultaneously.
Polyakov's work focuses on HCP engagement within immunology, a therapeutic area that requires precise, clinically grounded messaging. Her perspective will address how marketing teams build credibility with specialist audiences.
Anderson oversees the operational side of digital and omnichannel execution, offering a practical view of how marketing strategy translates into day-to-day campaign infrastructure.
Adler connects pipeline strategy directly to market access planning, providing insight into how access considerations are being built into commercial decisions earlier in the product lifecycle.
Nwokorie brings broad commercial marketing experience from one of the industry's larger global organizations, offering perspective on how marketing strategy scales across diverse portfolios and markets.
Together, these speakers represent a cross-section of the commercial challenges currently facing the industry, spanning obesity, immunology, access, digital operations, and pipeline strategy. Their combined participation is intended to give attendees a practical, multi-angle view of how senior leaders are addressing shared commercial pressures across different parts of the organization.